Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily Rubinstein

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Clinical Pharmacology and Therapeutics|March 5, 2023
A Structured Process to Identify Fit-for-Purpose Study Design and Data to Generate Valid and Transparent Real-World Evidence for Regulatory UsesNicolle M Gatto, Sarah E Vititoe, Emily Rubinstein, et al.
BMC Infectious Diseases|February 15, 2022
Characterizing patients with rare mucormycosis infections using real-world dataYayue Zhang, Anita H Sung, Emily Rubinstein, et al.
Clinical Pharmacology and Therapeutics|October 30, 2021
The Structured Process to Identify Fit-For-Purpose Data: A Data Feasibility Assessment FrameworkNicolle M Gatto, Ulka B Campbell, Emily Rubinstein, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 10, 2020
Real-world outcomes associated with standard half-life and extended half-life factor replacement products for treatment of haemophilia A and BAmit Chhabra, Dean Spurden, Patrick F Fogarty, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Clinical Pharmacology and Therapeutics|March 5, 2023
A Structured Process to Identify Fit-for-Purpose Study Design and Data to Generate Valid and Transparent Real-World Evidence for Regulatory UsesNicolle M Gatto, Sarah E Vititoe, Emily Rubinstein, et al.
BMC Infectious Diseases|February 15, 2022
Characterizing patients with rare mucormycosis infections using real-world dataYayue Zhang, Anita H Sung, Emily Rubinstein, et al.
Clinical Pharmacology and Therapeutics|October 30, 2021
The Structured Process to Identify Fit-For-Purpose Data: A Data Feasibility Assessment FrameworkNicolle M Gatto, Ulka B Campbell, Emily Rubinstein, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 10, 2020
Real-world outcomes associated with standard half-life and extended half-life factor replacement products for treatment of haemophilia A and BAmit Chhabra, Dean Spurden, Patrick F Fogarty, et al.
Pageof 1